Ivacaftor is a medication specifically designed for the treatment of cystic fibrosis (CF) in patients with certain mutations in the CFTR gene. As a CFTR potentiator, ivacaftor helps to improve the function of the defective protein produced by the CFTR gene, thereby enhancing chloride transport across cell membranes and improving respiratory and digestive functions.
